PCNA, proliferating cell nuclear antigen, 5111

N. diseases: 581; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 Biomarker disease BEFREE NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA. 30811506 2019
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 Biomarker disease BEFREE Our study demonstrates that the KSHV v-cyclin and cellular CDK6 kinase phosphorylate NPM on threonine 199 (Thr199) in de novo and naturally KSHV-infected cells and that NPM is phosphorylated to the same site in primary KS tumors. 20333249 2010
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 Biomarker disease BEFREE Viral K-cyclin derived from Kaposi's sarcoma-associated herpesvirus is homologous with mammalian D-type cyclins. 20331971 2010
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 Biomarker disease BEFREE Cyclin D family members are cellular protooncogenes, and their viral homologues in the Kaposi's sarcoma-associated herpesvirus (KSHV, human herpesvirus type 8 [HHV-8]) and the closely related Herpesvirus saimiri have been implicated as putative cofactors of viral transformation and pathogenesis. 11238594 2001
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 Biomarker disease BEFREE The production of vascular endothelial growth factor (VEGF) and certain proliferation markers (proliferating cell nuclear antigen and Ki-67) were significantly lower in Kaposi's sarcomas from NAC-treated mice than from control mice. 11719447 2001
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 AlteredExpression disease BEFREE While vCYC (AKS 6 of 6; CKS 3 of 3), vMIP-I (AKS 5 of 6, CKS 3 of 3), vBCL2 (AKS 6 of 6; CKS 3 of 3), and vIRF1 (AKS 5 of 6, CKS 3 of 3) transcripts were detected in both AKS and CKS, vGCR and HIV-1 Tat were expressed only in AKS samples (vGCR: AKS 3 of 6, CKS 0 of 3; Tat: AKS 4 of 6, CKS 0 of 3). vMIPII, vCBP, and vIL6 expression were not detected in any KS samples. 10662620 2000
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 Biomarker disease BEFREE The pattern of viral (HHV-8 v-cyclin) and cellular (p27Kip1) regulators of cell cycle expressed by CRO-AP/6, together with the results of growth fraction analysis, point to abrogation of the physiological inverse relationship between proliferation and p27Kip1 expression. 10914556 2000
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 AlteredExpression disease BEFREE The remaining cases were negative or weakly staining; v-cyclin transcript load was higher in early Kaposi sarcoma. 10645225 1999
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 Biomarker disease BEFREE These results suggest that v-cyclin may exert both growth-promoting and apoptotic functions in KS, depending on factors regulating CDK6 and v-Bcl-2 levels. 10519412 1999
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 Biomarker disease BEFREE Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) encodes a functional cyclin (vCYC) which is expressed during latency and can direct phosphorylation of pRB. 9882349 1999
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.100 Biomarker disease BEFREE In situ hybridization indicated that mRNAs for v-cyclin D and kaposin, an HHV-8 latency-associated gene, were present in approximately 1% of the spindle cells in early patch lesions and approximately 60% of the spindle cells in late nodular lesions of Kaposi's sarcoma. 9414174 1997